Metabolic Modulators Research Ltd (MMRL) is a biotechnology and pharmaceutical company that performs research in areas concerned with the metabolism of the energy - producing cellular fuels, fatty acids and carbohydrates.

Formed in 1997, MMRL develops and commercializes technology related to the control and optimization of the metabolism of these fuels. As a spin-off company of the University of Alberta, MMRL laboratories are located on campus in close proximity to the Faculty of Medicine.

MMRL, through its research activities, has identified a number of targets within these energy producing pathways that are susceptible to drug - induced regulation.

MMRL aims to develop this novel class of drugs, known as metabolic modulators, for the clinical management of a variety of cardiovascular and metabolic diseases, including congestive heart failure cardiac ischemia and diabetes.